ClassID:

97013

C07K14/6555 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Hormones; Somatostatins at least 1 amino acid in D-form

Recent Application in this class:
#1
20260001906
2026-01-01

Method for Synthesizing Amide and/or Polypeptide Using Temporary Protected Amino Acid as Ammonia Component

#2
20180340012
2018-11-29

METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM

#3
20180072774
2018-03-15

Backbone-cyclized peptidomimetics with GLP-1R modulating activity

#4
20170157260
2017-06-08

Glycosylated polypeptide and drug composition containing said polypeptide

#5
20160368961
2016-12-22

Glycosylated polypeptide and drug composition containing said polypeptide

#6
20160213793
2016-07-28

Somatostatin analogs with inhibitory activity to growth hormone release

#7
20160185822
2016-06-30

Cortistatin analogues for the treatment of inflammatory and/or immune diseases

#8
20150284424
2015-10-08

BOC AND FMOC SOLID PHASE PEPTIDE SYNTHESIS

#9
20150252095
2015-09-10

Apolipoprotein AIV as an antidiabetic peptide

#10
20150203554
2015-07-23

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

#11
20140336116
2014-11-13

Glycosylated polypeptide and drug composition containing said polypeptide

#12
20140315800
2014-10-23

Glycosylated polypeptide and drug composition containing said polypeptide

#13
20140179598
2014-06-26

Somatostatin analogs with inhibitory activity to growth hormone release

#14
20140005107
2014-01-02

Apolipoprotein AIV as an antidiabetic peptide

#15
20130338337
2013-12-19

Boc and Fmoc solid phase peptide synthesis

#16
20130252892
2013-09-26

Octapeptide compounds and therapeutic use thereof

#17
20130244947
2013-09-19

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

#18
20130035286
2013-02-07

Pharmaceutical Composition Comprising Cyclic Somatostatin Analogues

#19
20120108748
2012-05-03

Solid phase peptide synthesis of peptide alcohols

#20
20120035117
2012-02-09

Process for synthesis of cyclic octapeptide

#21
20110243845
2011-10-06

Somatostatin analogs with inhibitory activity to growth hormone release

#22
20110136741
2011-06-09

DICARBA-ANALOGUES OF OCTREOTIDE

#23
20100323964
2010-12-23

Non-selective somatostatin analogues

#24
20100323963
2010-12-23

CONJUGATES OF DISORAZOLES AND THEIR DERIVATIVES WITH CELL-BINDING MOLECULES, NOVEL DISORAZOLE DERIVATIVES, PROCESSES OF MANUFACTURING AND USES THEREOF

#25
20100317580
2010-12-16

Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof

#26
20100240865
2010-09-23

PROCESS FOR PRODUCTION OF CYCLIC PEPTIDES

#27
20100179304
2010-07-15

Somatostatin-dopamine chimeric analogs

#28
20100160604
2010-06-24

Boc and Fmoc solid phase peptide synthesis

#29
20100137559
2010-06-03

PROCESS FOR PRODUCTION OF CYCLIC PEPTIDES

#30
20090281031
2009-11-12

Methods and compositions related to improving properties of pharmacological agents targeting nervous system

#31
20090275501
2009-11-05

Somatostatin-dopamine chimeric analogs

#32
20090253638
2009-10-08

Somatostatin antagonists

#33
20090137462
2009-05-28

Pharmaceutical composition comprising cyclic somatostatin analogues

#34
20080292548
2008-11-27

Compounds and methods for F labeled agents

#35
20080139703
2008-06-12

Method for Preparing Lipid-Spacer-Reactive Functional Group-Peptide

#36
20080108790
2008-05-08

S-Alkyl-Sulphenyl Protection Groups in Solid-Phase Synthesis

#37
20080102110
2008-05-01

Method for Preparing Lipid-Spacer-Reactive Functional Group-Peptide

#38
20080097079
2008-04-24

Cyclization of a Peptide

#39
20080090758
2008-04-17

Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof

#40
20080090756
2008-04-17

Somatostatin agonists

#41
20070093645
2007-04-26

Peptide vectors

#42
20070093412
2007-04-26

Pharmaceutical composition comprising cyclic somatostatin analogues

#43
20070066516
2007-03-22

Compounds comprising cyclized somatostatin receptor binding peptides

#44
20070041902
2007-02-22

Somatostatin analogs with inhibitory activity to growth hormone release

#45
20060258838
2006-11-16

Preparation of somatostatin peptides

#46
20060258572
2006-11-16

Somatostatin-dopamine chimeric analogs

#47
20060211607
2006-09-21

Somatostatin-dopamine chimeric analogs

#48
20060155107
2006-07-13

SSTR1-selective analogs

#49
20060069017
2006-03-30

Somatostatin analog and uses thereof

#50
20060063704
2006-03-23

Somatostatin-dopamine chimeric analogs

#51
20050164922
2005-07-28

Somatostatin agonists

#52
20050118099
2005-06-02

Thiol-mediated drug attachment to targeting peptides

#53
20050090429
2005-04-28

Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging

#54
20050043226
2005-02-24

Conformationally constrained backbone cyclized somatostatin analogs